As the burden of neurodegenerative diseases grows, so does the urgency to find smarter, more nuanced ways to protect the brain. Researchers are now looking beyond single targets, instead exploring how interconnected systems—from blood vessels to cellular cleanup processes—can be tuned to preserve cognition and delay disease onset.
In recent studies, dihydromyricetin, a natural compound, was found to support brain health by promoting angiogenesis through the VEGFR2 pathway—offering potential benefits in vascular dementia. Meanwhile, new imaging data suggest that patterns of cortical network atrophy could help predict who will progress to dementia in Lewy body diseases. And in Alzheimer’s models, Urolithin A appears to reduce harmful cellular stress by modulating autophagy-related pathways. Together, these findings reflect a growing shift toward integrative strategies that support the brain’s ability to adapt, repair, and resist decline.
1. Dihydromyricetin ameliorates vascular dementia by promoting angiogenesis via the VEGFR2 pathway: Network pharmacology, molecular docking and experimental validation
A deep dive into how our gut microbes and the cAMP-PKA signaling pathway work together to influence brain health. From Alzheimer’s to depression, this interaction could unlock new ways to manage neurological and psychiatric disorders—using everything from probiotics to plant compounds.
2. Regional cortical network atrophy predicts progression to dementia in the Lewy body diseases
A thoracic-specific spinal cord organoid (enTsOrg) mimics native circuitry and restores hind-limb function in spinal cord-injured mice. This segment-matched transplant supports neuron maturation, connectivity, and recovery—highlighting a promising direction for targeted spinal repair.
3. Neuroprotective effect of Urolithin A via downregulating VDAC1-mediated autophagy in Alzheimer’s disease
Induced pluripotent stem cell (iPSC) technologies are reshaping Parkinson’s research by enabling the generation of patient-derived dopaminergic neurons. This review explores evolving methods—from small molecules to 3D organoids—and their potential in disease modeling, drug screening, and future cell replacement therapies.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
